As pharmaceutical companies seek to bring manufacturing back to the United States, high construction costs, lengthy timelines, and equipment availability present significant challenges. In this article for Pharmaceutical Technology, Experic CEO Matthew Mollan, Ph.D., and Federal Equipment Company President Adam Covitt explore how CDMOs with expandable manufacturing space can collaborate with equipment resellers and original equipment manufacturers (OEMs) to accelerate domestic production, reduce capital investment, and build more flexible pharmaceutical supply chains.